INTUITIVE SURGICAL WKN: 888024 ISIN: US46120E6023 Kürzel: ISRG Forum: Aktien Thema: Hauptdiskussion

so rein bewertungstechnisch ist das aber nicht gerade günstig aktuell, oder? es ist ja nicht so, dass wir hier 20 oder 30 % im Jahr wachsen

Wow mega zahlen. Nachbörslich fast auf 300$. Das ath sollte da zeitnah auch kein Problem sein

Intuitive Surgical Q1-2023 Earnings EPS $1.23 vs $1.2 Rev $1.696B vs $1.59B（YoY +14%） https://pbs.twimg.com/media/FuBbfL2WwAIB64k?format=png

Es kennt noch keiner so wirklich die Aktie

Ein Einstieg lohnt sich klein beginnen wenn ich denke das heute die erste Nieren OP gemacht wurde dürfte das System jetzt zukunftstauglich für jedes Spital sein

10 nachgelegt für 247$

sollten die $244,x nicht halten, geht's Richtung ~$220..

Immer noch PE über 50 hier...weiss nicht ob das hier ein Einstieg wert ist, unter $200 könnte ich mir einen kleinen Einstieg vorstellen

Danke

https://www.earningswhispers.com/epsdetails/isrg

https://seekingalpha.com/news/3923687-intuitive-shares-slumped-after-preliminary-q4-and-fy-revenue-missed-consensus-mark Intuitive shares slumped after preliminary Q4 and FY revenue missed consensus mark Intuitive (NASDAQ:ISRG) shares down after Q4 preliminary revenue fell short of consensus. The company expects Q4 revenue of $1.66B (+7% Y/Y) vs. consensus of $1.69B and FY revenue growth of 9% Y/Y to $6.22B vs. consensus of $6.26B Worldwide da Vinci procedures grew approximately 18% Y/Y in Q4 and FY2022. The compound annual growth rate between 4Q19 to 4Q22 was approximately 14% and between FY2019 to FY2022 was approximately 15%. The company expects worldwide da Vinci procedures to increase approximately 12% to 16% in 2023. Commenting on the announcement, Intuitive CEO Gary Guthart said, “Our customers continued to grow their adoption of our training, products, and services in the fourth quarter and for the full year. We remain focused on supporting our customers’ drive to improve the quadruple aim in acute interventions.” ...

Was ist denn hier passiert ?

https://www.google.com/amp/s/www.marketscreener.com/amp/quote/stock/INTUITIVE-SURGICAL-INC-9740/news/Intuitive-Surgical-Purchase-Agreement-Form-8-K-42081721/

Die liefern immer. Tolle langfrist Anlage, allerdings auch immer hoch bewertet

Intuitive Surgical Quartalszahlen: Gewinnerwartung und Umsatzprognose im Q3 übertroffen https://m.de.investing.com/news/stock-market-news/intuitive-surgical-quartalszahlen-gewinnerwartung-und-umsatzprognose-im-q3-ubertroffen-2313580

Intuitive Surgical Non-GAAP EPS of $1.19 beats by $0.07, revenue of $1.56B beats by $40M https://seekingalpha.com/news/3892397-intuitive-surgical-non-gaap-eps-of-1_19-beats-0_07-revenue-of-1_56b-beats-40m • Intuitive Surgical press release (NASDAQ:ISRG): Q3 Non-GAAP EPS of $1.19 beats by $0.07. • Revenue of $1.56B (+11.4% Y/Y) beats by $40M. • Worldwide da Vinci procedures grew approximately 20% compared with the third quarter of 2021. The third quarter of 2021 reflected disruption caused by the COVID-19 pandemic, which impacted our procedures. The compound annual growth rate between the third quarter of 2019 and the third quarter of 2022 was approximately 16%. • The Company placed 305 da Vinci Surgical Systems, a decrease of 9% compared with 336 in the third quarter of 2021. • The Company grew its da Vinci Surgical System installed base to 7,364 systems as of September 30, 2022, an increase of 13% compared with 6,525 as of the end of the third quarter of 2021.